The bill
To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.
HR. 6321, 119th Congress — read as touching Medical Devices.
To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.
Bill ID: 119/hr/6321
Last Updated: November 28, 2025
Sponsored by
Rep. Gottheimer, Josh [D-NJ-5]
ID: G000583
Follow the money
The sponsor
Rep. Gottheimer, Josh [D-NJ-5]
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
$193,281 raised
29 itemised contributions to this sponsor, pulled from FEC filings.
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Invalid Date
Introduced
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
🏛️
Committee Review
🗳️
Floor Action
✅
Passed Senate
🏛️
House Review
🎉
Passed Congress
🖊️
Presidential Action
⚖️
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
No summary available
💰 Campaign Finance Network
Rep. Gottheimer, Josh [D-NJ-5]
Congress 119 • 2024 Election Cycle
Total Contributions
$193,281
21 donors
PACs
$0
Organizations
$63,374
Committees
$0
Individuals
$129,907
No PAC contributions found
1
AMERICAN EXPRESS
$33,562
2
PAYROLL DATA PROCESSING
$24,762
3
EASTERN BAND OF CHEROKEE INDIANS
$3,300
4
SEKAS LAW GROUP LLC
$1,500
5
SANDOR F. GENET & ASSOCIATES, P.A.
$250
No committee contributions found
1
FIRESTONE MILKEN, SARAH
$23,100
2
WEBB, DAN K.
$13,200
3
MCKNIGHT, ANDREW
$10,000
4
CRETELLA, JEANNE
$10,000
5
WOODSIDE, KEVIN E.
$6,600
6
CARSON, RUSSELL L.
$6,600
7
ROSMAN, ELIZABETH
$6,600
8
BOECKMANN, ALAN
$6,600
9
MCLEAN, TERRENCE
$6,600
10
MANN, TRACY
$6,600
11
REYNOLDS, RALPH
$6,600
12
HANOVER, ADAM
$6,600
13
ROBERTSON, WILHELMINA E.
$5,807
14
VIXAMAR, STEVE
$5,000
15
KNIGHTS, CLIFFORD
$5,000
16
CUBERO, MARIA
$5,000
Donor Network - Rep. Gottheimer, Josh [D-NJ-5]
PACs
Organizations
Individuals
Politicians
Hub layout: Politicians in center, donors arranged by type in rings around them.
Loading...
Showing 52 nodes and 29 connections (60 secondary connections hidden)
Total contributions: $193,281
Top Donors - Rep. Gottheimer, Josh [D-NJ-5]
Showing top 21 donors by contribution amount
5 Orgs16 Individuals
Industry Impact
Which industries are materially affected by specific provisions in this bill. 3 helped.
- +Medical Devicesconfidence 0.90
Section 2(a)(2)(B) adds coverage for lung cancer biomarker testing under Medicare, which will increase demand for diagnostic tests and related medical devices used to detect biomarkers in tissue, blood, or bodily fluids.
- +Biotech & Researchconfidence 0.85
Section 2(a)(2)(B) mandates Medicare coverage of lung cancer biomarker testing, which will drive utilization of biomarker assays developed by biotech firms (e.g., gene or protein-based tests), expanding their market.
- +Hospitals & Health Systemsconfidence 0.80
Section 2(b) requires Medicare payment of 100% of reasonable charges for lung cancer biomarker testing, increasing reimbursement for hospitals and health systems that provide these diagnostic services to Medicare beneficiaries.
Who funds the sponsor on these industries
For each industry this bill affects, here's what the sponsor (Rep. Gottheimer, Josh [D-NJ-5])received from donors associated with that industry during the 2022–present cycles. Donations are not proof of intent — they are a record of who funds the people writing the law.
Industries this bill HELPS
- Biotech & Research$1,000from 1 contribution
- TOOHEY, BRIAN$1,000
- from 1 contribution
- SPARKS, DENNIS$500